Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
M RuggeriF Rodeghiero

Abstract

While many studies have demonstrated the pathogenetic role of inherited deficiency of natural clotting inhibitors in patients in the development of deep vein thrombosis of lower limbs, no data are available on the prevalence of these abnormalities in patients with upper vein thrombosis. In this study, antithrombin III, protein C, protein S, plasminogen, resistance to activated protein C and factor V Leiden mutation were assayed in 27 consecutive patients with thrombosis of upper extremities. Only two patients (7.4%) showed a congenital defect (one patient with deficiency of protein C, confirmed by family study, and one patient with factor V Leiden mutation). Anticardiolipin antibodies were also measured and four patients (14.8%) had increased levels, confirmed on a subsequent occasion 3 months later. Eighteen out of 27 (67%) had a predisposing or triggering factor, thus emphasizing the role of physical stress in the development of upper vein thrombosis. At variance with what is observed in deep vein thrombosis of the lower limbs, inherited clotting abnormalities seem to be rarely responsible for upper vein thrombosis, whereas anticardiolipin antibodies and cancer are implicated in a significant proportion of cases.

Citations

Sep 29, 2009·Internal and Emergency Medicine·Luca Spiezia, Paolo Simioni
Jan 29, 2011·Current Treatment Options in Cardiovascular Medicine·Ronan Margey, Robert M Schainfeld
May 24, 2005·The Journal of Infection·Pedro LinaresJose Luis Olcoz
Aug 8, 2001·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·A HingoraniW Yorkovich
Jul 29, 2000·Harefuah·M Misgav, S Berliner
Jul 30, 2004·American Journal of Hematology·Mariela F HendlerMaria A Lazzari
Apr 3, 2001·American Journal of Hematology·F W LeebeekM C Kappers-Klunne
May 30, 2009·Thrombosis Research·Dominik BerzaczyRobert A Bucek
Mar 27, 2004·Transfusion·R B CovinAgnes Aysola
May 20, 2008·Journal of Thrombosis and Haemostasis : JTH·L E FlintermanC J M Doggen
Jul 31, 2013·Current Problems in Pediatric and Adolescent Health Care·Michael Silvey, Shannon L Carpenter
Mar 4, 2008·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Andrew D WhymarkHaytham Kubba
Mar 24, 2005·Blood Reviews·Christine L Hann, Michael B Streiff
Sep 11, 2012·Best Practice & Research. Clinical Haematology·Manuel MonrealEmmanouil Papadakis
Feb 24, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A VayáJ Aznar
Feb 1, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Salvatore Santo SignorelliMassimiliano Anzaldi
Nov 12, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Navin PaiKanjaksha Ghosh
Oct 3, 2002·Circulation·Hylton V Joffe, Samuel Z Goldhaber
Jul 21, 2004·Circulation·Ida MartinelliPier Mannuccio Mannucci
Jul 17, 1999·Current Opinion in Pulmonary Medicine·P Prandoni, E Bernardi
Jul 5, 2017·Internal Medicine·Yuichiro HabaFumihiko Ishimaru

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.